Matches in Wikidata for { <http://www.wikidata.org/entity/Q65390758> ?p ?o ?g. }
Showing items 1 to 40 of
40
with 100 items per page.
- Q65390758 description "clinical trial" @default.
- Q65390758 description "ensayu clínicu" @default.
- Q65390758 description "klinisch onderzoek" @default.
- Q65390758 description "клінічне випробування" @default.
- Q65390758 description "կլինիկական փորձարկում" @default.
- Q65390758 name "Efficacy and Safety Study of Magnesium Iron Hydroxycarbonate for the Reduction of High Blood Phosphate in Hemodialysis Patients" @default.
- Q65390758 name "Efficacy and Safety Study of Magnesium Iron Hydroxycarbonate for the Reduction of High Blood Phosphate in Hemodialysis Patients" @default.
- Q65390758 type Item @default.
- Q65390758 label "Efficacy and Safety Study of Magnesium Iron Hydroxycarbonate for the Reduction of High Blood Phosphate in Hemodialysis Patients" @default.
- Q65390758 label "Efficacy and Safety Study of Magnesium Iron Hydroxycarbonate for the Reduction of High Blood Phosphate in Hemodialysis Patients" @default.
- Q65390758 prefLabel "Efficacy and Safety Study of Magnesium Iron Hydroxycarbonate for the Reduction of High Blood Phosphate in Hemodialysis Patients" @default.
- Q65390758 prefLabel "Efficacy and Safety Study of Magnesium Iron Hydroxycarbonate for the Reduction of High Blood Phosphate in Hemodialysis Patients" @default.
- Q65390758 P1050 Q65390758-B79B6288-465D-457A-B325-52C79C85E0AA @default.
- Q65390758 P1132 Q65390758-DF37567C-13A6-4B9F-9CAD-46435A460689 @default.
- Q65390758 P1476 Q65390758-838C9C48-8C2D-48EA-B99D-18B7A4562155 @default.
- Q65390758 P17 Q65390758-3FBDCB45-25E9-4BEB-97FB-5870BF664704 @default.
- Q65390758 P17 Q65390758-67A6989B-1C8C-42D1-BA41-56F4B380240B @default.
- Q65390758 P2899 Q65390758-22F0E76C-96F8-4E47-B406-E884467B026F @default.
- Q65390758 P3098 Q65390758-C76E1C4E-E988-4EB0-9574-F3AA573CAA27 @default.
- Q65390758 P31 Q65390758-787EA785-CECB-47A1-B63C-714E91BD0574 @default.
- Q65390758 P580 Q65390758-2655AD5A-6D12-46EE-B427-511C583B3088 @default.
- Q65390758 P582 Q65390758-DEB807AE-22C7-42DC-AC4E-E96043E62240 @default.
- Q65390758 P6099 Q65390758-17BF6BB0-46D0-4F0E-9C43-D45FF2B3A6A7 @default.
- Q65390758 P6153 Q65390758-2D389633-DFE6-4FF0-9FB6-613AD299AEE6 @default.
- Q65390758 P6153 Q65390758-7CB4E89F-2F3E-4115-A564-0EAD664B3275 @default.
- Q65390758 P8363 Q65390758-73FDED85-822D-4FF1-9658-6CEFC7FD7D44 @default.
- Q65390758 P1050 Q1641062 @default.
- Q65390758 P1132 "+111" @default.
- Q65390758 P1476 "A Multicentre Phase II Study With Magnesium Iron Hydroxycarbonate: an Open-label, Dose-ranging Phase Followed by a Placebo-controlled, Double-blind, Parallel-group Comparison in Haemodialysis Subjects With Hyperphosphataemia" @default.
- Q65390758 P17 Q145 @default.
- Q65390758 P17 Q30 @default.
- Q65390758 P2899 "+18" @default.
- Q65390758 P3098 "NCT00317694" @default.
- Q65390758 P31 Q30612 @default.
- Q65390758 P580 "2006-03-01T00:00:00Z" @default.
- Q65390758 P582 "2007-06-01T00:00:00Z" @default.
- Q65390758 P6099 Q42824440 @default.
- Q65390758 P6153 Q472316 @default.
- Q65390758 P6153 Q7374408 @default.
- Q65390758 P8363 Q78089383 @default.